NM_005591.4:c.493A>C
Variant summary
Our verdict is Uncertain significance. The variant received 4 ACMG points: 4P and 0B. PM2PP3_Moderate
The NM_005591.4(MRE11):c.493A>C(p.Ser165Arg) variant causes a missense change involving the alteration of a conserved nucleotide. The variant allele was found at a frequency of 0.000000684 in 1,461,346 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. S165C) has been classified as Uncertain significance.
Frequency
Consequence
NM_005591.4 missense
Scores
Clinical Significance
Conservation
Publications
- ataxia-telangiectasia-like disorder 1Inheritance: AR Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: Labcorp Genetics (formerly Invitae), G2P, Orphanet, Ambry Genetics
- breast cancerInheritance: AD Classification: NO_KNOWN Submitted by: Ambry Genetics
- familial ovarian cancerInheritance: AD Classification: NO_KNOWN Submitted by: ClinGen
- hereditary breast carcinomaInheritance: AD Classification: NO_KNOWN Submitted by: ClinGen
- prostate cancerInheritance: AD Classification: NO_KNOWN Submitted by: Ambry Genetics
Genome browser will be placed here
ACMG classification
Our verdict: Uncertain_significance. The variant received 4 ACMG points.
Variant Effect in Transcripts
ACMG analysis was done for transcript: NM_005591.4. You can select a different transcript below to see updated ACMG assignments.
RefSeq Transcripts
| Selected | Gene | Transcript | Tags | HGVSc | HGVSp | Effect | Exon Rank | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|---|
| MRE11 | NM_005591.4 | MANE Select | c.493A>C | p.Ser165Arg | missense | Exon 6 of 20 | NP_005582.1 | ||
| MRE11 | NM_001440460.1 | c.493A>C | p.Ser165Arg | missense | Exon 6 of 21 | NP_001427389.1 | |||
| MRE11 | NM_001440461.1 | c.493A>C | p.Ser165Arg | missense | Exon 6 of 21 | NP_001427390.1 |
Ensembl Transcripts
| Selected | Gene | Transcript | Tags | HGVSc | HGVSp | Effect | Exon Rank | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|---|
| MRE11 | ENST00000323929.8 | TSL:1 MANE Select | c.493A>C | p.Ser165Arg | missense | Exon 6 of 20 | ENSP00000325863.4 | ||
| MRE11 | ENST00000323977.7 | TSL:1 | c.493A>C | p.Ser165Arg | missense | Exon 6 of 19 | ENSP00000326094.3 | ||
| MRE11 | ENST00000540013.5 | TSL:1 | c.493A>C | p.Ser165Arg | missense | Exon 6 of 8 | ENSP00000440986.1 |
Frequencies
GnomAD3 genomes Cov.: 32
GnomAD2 exomes AF: 0.00000398 AC: 1AN: 251046 AF XY: 0.00000737 show subpopulations
GnomAD4 exome AF: 6.84e-7 AC: 1AN: 1461346Hom.: 0 Cov.: 30 AF XY: 0.00000138 AC XY: 1AN XY: 727004 show subpopulations
GnomAD4 genome Cov.: 32
ClinVar
Submissions by phenotype
Hereditary cancer-predisposing syndrome Uncertain:1
The p.S165R variant (also known as c.493A>C), located in coding exon 5 of the MRE11A gene, results from an A to C substitution at nucleotide position 493. The serine at codon 165 is replaced by arginine, an amino acid with dissimilar properties. This amino acid position is conserved. In addition, this alteration is predicted to be deleterious by in silico analysis. Since supporting evidence is limited at this time, the clinical significance of this alteration remains unclear.
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at